While Cyclophosphamide (CTX) slowed growth, it induced earlier alterations in oxygenation: mSO2 was higher in the CTX group on Day 7 (<i>P</i> < 0.05), before tumor volume divergence became evident, whereas Hb and HbT were lower at the mid-treatment stage. Here, GSTM1 is linked to neoplasm.